サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/10/10 | 4,300 | 4,300 | 4,165 | 4,175 | -105 | -2.5% | 473,500 |
| 2019/10/09 | 4,195 | 4,310 | 4,160 | 4,280 | +65 | +1.5% | 493,200 |
| 2019/10/08 | 4,280 | 4,305 | 4,200 | 4,215 | -90 | -2.1% | 465,400 |
| 2019/10/07 | 4,340 | 4,345 | 4,235 | 4,305 | +5 | +0.1% | 410,800 |
| 2019/10/04 | 4,270 | 4,375 | 4,240 | 4,300 | +30 | +0.7% | 757,000 |
| 2019/10/03 | 4,170 | 4,275 | 4,155 | 4,270 | +15 | +0.4% | 657,200 |
| 2019/10/02 | 4,300 | 4,340 | 4,180 | 4,255 | -115 | -2.6% | 926,700 |
| 2019/10/01 | 4,510 | 4,520 | 4,355 | 4,370 | -120 | -2.7% | 746,100 |
| 2019/09/30 | 4,440 | 4,505 | 4,325 | 4,490 | ±0 | ±0% | 1,044,500 |
| 2019/09/27 | 4,560 | 4,620 | 4,430 | 4,490 | +30 | +0.7% | 2,205,600 |
| 2019/09/26 | 4,295 | 4,550 | 4,275 | 4,460 | +255 | +6.1% | 3,308,700 |
| 2019/09/25 | 4,115 | 4,240 | 4,080 | 4,205 | +155 | +3.8% | 1,752,500 |
| 2019/09/24 | 4,065 | 4,380 | 3,990 | 4,050 | -135 | -3.2% | 3,335,800 |
| 2019/09/20 | 3,950 | 4,240 | 3,935 | 4,185 | +645 | +18.2% | 5,720,000 |
| 2019/09/19 | 3,585 | 3,655 | 3,525 | 3,540 | -15 | -0.4% | 689,800 |
| 2019/09/18 | 3,400 | 3,575 | 3,380 | 3,555 | +145 | +4.3% | 969,000 |
| 2019/09/17 | 3,365 | 3,500 | 3,325 | 3,410 | +100 | +3% | 701,800 |
| 2019/09/13 | 3,345 | 3,350 | 3,270 | 3,310 | -10 | -0.3% | 376,100 |
| 2019/09/12 | 3,450 | 3,485 | 3,310 | 3,320 | -155 | -4.5% | 642,800 |
| 2019/09/11 | 3,335 | 3,480 | 3,320 | 3,475 | +145 | +4.4% | 605,900 |
| 2019/09/10 | 3,310 | 3,330 | 3,280 | 3,330 | +15 | +0.5% | 202,600 |
| 2019/09/09 | 3,330 | 3,340 | 3,270 | 3,315 | -40 | -1.2% | 302,800 |
| 2019/09/06 | 3,330 | 3,375 | 3,320 | 3,355 | +15 | +0.4% | 263,400 |
| 2019/09/05 | 3,340 | 3,390 | 3,315 | 3,340 | +45 | +1.4% | 545,200 |
| 2019/09/04 | 3,450 | 3,470 | 3,290 | 3,295 | -190 | -5.5% | 1,241,200 |
| 2019/09/03 | 3,640 | 3,650 | 3,460 | 3,485 | -115 | -3.2% | 1,719,600 |
| 2019/09/02 | 3,410 | 3,935 | 3,385 | 3,600 | +260 | +7.8% | 5,420,100 |
| 2019/08/30 | 3,255 | 3,375 | 3,210 | 3,340 | +165 | +5.2% | 421,500 |
| 2019/08/29 | 3,300 | 3,320 | 3,150 | 3,175 | -115 | -3.5% | 332,500 |
| 2019/08/28 | 3,380 | 3,400 | 3,275 | 3,290 | -90 | -2.7% | 261,100 |
| 2019/08/27 | 3,485 | 3,490 | 3,360 | 3,380 | +25 | +0.7% | 384,800 |
| 2019/08/26 | 3,335 | 3,455 | 3,300 | 3,355 | -70 | -2% | 441,300 |
| 2019/08/23 | 3,400 | 3,445 | 3,350 | 3,425 | +25 | +0.7% | 205,400 |
| 2019/08/22 | 3,505 | 3,540 | 3,395 | 3,400 | -50 | -1.4% | 430,700 |
| 2019/08/21 | 3,385 | 3,515 | 3,320 | 3,450 | -5 | -0.1% | 598,400 |
| 2019/08/20 | 3,190 | 3,460 | 3,175 | 3,455 | +285 | +9% | 864,400 |
| 2019/08/19 | 3,145 | 3,190 | 3,125 | 3,170 | +40 | +1.3% | 268,000 |
| 2019/08/16 | 3,035 | 3,140 | 3,020 | 3,130 | +105 | +3.5% | 284,500 |
| 2019/08/15 | 3,025 | 3,075 | 3,020 | 3,025 | -90 | -2.9% | 337,200 |
| 2019/08/14 | 3,135 | 3,140 | 3,085 | 3,115 | +5 | +0.2% | 189,900 |
| 2019/08/13 | 3,090 | 3,140 | 3,085 | 3,110 | -50 | -1.6% | 212,700 |
| 2019/08/09 | 3,195 | 3,220 | 3,135 | 3,160 | -20 | -0.6% | 282,400 |
| 2019/08/08 | 3,055 | 3,195 | 3,050 | 3,180 | +85 | +2.7% | 494,200 |
| 2019/08/07 | 3,200 | 3,200 | 3,085 | 3,095 | -55 | -1.7% | 328,800 |
| 2019/08/06 | 2,990 | 3,155 | 2,961 | 3,150 | +35 | +1.1% | 588,700 |
| 2019/08/05 | 3,245 | 3,445 | 2,990 | 3,115 | -185 | -5.6% | 1,821,300 |
| 2019/08/02 | 3,370 | 3,395 | 3,260 | 3,300 | -120 | -3.5% | 360,000 |
| 2019/08/01 | 3,400 | 3,430 | 3,380 | 3,420 | +20 | +0.6% | 175,200 |
| 2019/07/31 | 3,430 | 3,440 | 3,380 | 3,400 | -45 | -1.3% | 172,300 |
| 2019/07/30 | 3,440 | 3,480 | 3,365 | 3,445 | +55 | +1.6% | 357,500 |
1351～
1400
件表示中 / 2453件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 228,200円 | - | - | 0.00% | - | 105.70倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 414,000円 | +30.5% | +111.0% | 4.59% | 11.67倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 383,500円 | +14.5% | -2.3% | 2.35% | 14.03倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 256,200円 | +15.0% | -7.3% | 2.73% | 8.41倍 | 0.79倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 451,000円 | +7.1% | -35.0% | 2.66% | 37.29倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
